WORLDWIDE TRADING & INVESTMENT GROUP LLC
WORLDWIDE TRADING & INVESTMENT GROUP LLC
Dubai, United Arab Emirates

COMPANY OVERVIEW

Company Album1

Basic Information
Worldwide Trading & Investment Group is the holding Company, part investment for the ELIS Pharmaceuticals Ltd, which is active in the creation of a world wide networking following a spirit of globalization of the pharmaceutical products. Our main focus is to provide a wide range of high quality pharmaceutical products toOur valued customers. Our full range of dosage form includes Tablets, Capsules, Soft Gels, Injectables, Eye / Ear drops, Syrups, Powders, Gels, medicated Ointments & creams, Vitamins, Oral suspensions. Most of our manufacturing facilities conform to WHO cGMP, in compliance with UK-B. P. & USP, we work with SGS for quality control, thereby complying with the stringent international regulatory specifications. We are committed to provide our customers with generic pharmaceuticals that are produced under internationally recognized B. P. (British Pharmacopoeia) U. S. P. quality standards in world class manufacturing facilities. Customer driven and strive to supply quality pharmaceuticals and generic drugs at significant savings for the benefit of our customers, world wide.
  • Transactions
    -
Business type
Manufacturer, Trading Company
Country / Region
Dubai, United Arab Emirates
Main ProductsTotal employees
11 - 50 People
Total Annual Revenue
US$10 Million - US$50 Million
Year established
2005
Certifications
-
Product Certifications
-
Patents
-
Trademarks
-
Main Markets

PRODUCT CAPACITY

Factory Information

Factory Size
Above 100,000 square meters
No. of Production Lines
4
Contract Manufacturing
Buyer Label Offered

R&D CAPACITY

Research & Development

Above 50 People

TRADE CAPABILITIES

Main Markets & Product(s)

Main markets
Total Revenue(%)
Main Product(s)
Verified
North America
11.11%
South America
11.11%
Eastern Europe
11.11%
Southeast Asia
11.11%
Africa
11.11%
Oceania
11.11%
Mid East
11.11%
Eastern Asia
11.11%
Western Europe
11.11%
Verified

Trade Ability

Total Annual Revenue
US$10 Million - US$50 Million